androgen deficiency
Showing 1 - 10 of 10
Androgen Metabolism, Metabolic Disease and Skeletal Muscle
Not yet recruiting
- Hypogonadism, Male
- +10 more
-
Dublin 9, IrelandBeaumont Hospital
Mar 16, 2023
Prostate Cancer, Insulin Resistance, Diabetes, Type 2 Trial in Buffalo (Pioglitazone 30 mg, Placebo)
Recruiting
- Prostate Cancer
- +3 more
- Pioglitazone 30 mg
- Placebo
-
Buffalo, New YorkDiabetes and Endocrinology Research Center of WNY
Oct 26, 2022
Pain, Opioid Use, Androgen Deficiency Trial in Boston (Testosterone Cypionate, Placebo)
Recruiting
- Pain
- +2 more
- Testosterone Cypionate
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 26, 2022
In-vitro Diagnostic Test to Predict COVID-19 Mortality and
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
-
Madrid, SpainHospital Universitario Ramon y Cajal
Feb 17, 2022
Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Gainesville, Jacksonville (Testosterone Enanthate,
Recruiting
- Spinal Cord Injury
- +19 more
- Testosterone Enanthate
- Locomotor Training
-
Gainesville, Florida
- +1 more
Aug 30, 2021
Androgen Deficiency, Depressive Symptoms, Stress, Psychological Trial in Florianópolis (Concurrent training, Eurycoma
Unknown status
- Androgen Deficiency
- +5 more
- Concurrent training
- Eurycoma longifolia
-
Florianópolis, Santa Catarina, BrazilSanta Catarina State University
Aug 12, 2019
Insulin Resistance, Type 2 Diabetes, Obesity Trial in Seattle (Acyline, Testosterone 1.62% gel, Letrozole)
Completed
- Insulin Resistance
- +4 more
- Acyline
- +4 more
-
Seattle, WashingtonUniversity of Washington
Apr 5, 2018
Registry of Hypogonadism in Men
Completed
- Male Hypogonadism
- +2 more
- Standard of Care
-
Halle (Saale), Germany
- +24 more
Aug 22, 2016
Hormones and Sexual Function Predict Outcomes in Revascularized
Completed
- Androgen Deficiency
- +6 more
-
Guttenberg, New Jersey
- +4 more
Aug 10, 2016
Healthy Subjects, Androgen Deficiency Trial in Evansville (, GSK971086)
Completed
- Healthy Subjects
- Androgen Deficiency
- placebo
- GSK971086
-
Evansville, IndianaGSK Investigational Site
Mar 15, 2012